Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.98 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.57 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.57 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.57 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.57 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
| ▸ | APEX1 | P27695 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Telenzepine SCHEMBL184401 | 0.99 | LMNA (1.00) | CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C9 | |
| Telenzepine SCHEMBL2006403 | 0.99 | CYP2D6 (0.98) | CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C9 | |
| Telenzepine SCHEMBL970991 | 0.99 | LMNA (1.00) | CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C9 | |
| Telenzepine SCHEMBL14973496 | 0.98 | ALDH1A1 (0.96) | CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL11192698 | 0.92 | ALDH1A1 (0.85) | CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL9431778 | 0.90 | ALDH1A1 (0.82) | CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL9727995 | 0.90 | ALDH1A1 (0.81) | CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL11187135 | 0.89 | CYP2D6 (0.80) | CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C9 | |
| Pirenzepine SCHEMBL935909 | 0.89 | ALDH1A1 (0.79) | CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL9431091 | 0.88 | ALDH1A1 (0.78) | CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5072 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3518898-B1 | PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY | CHILDRENS MEDICAL CT CORP (US) | 2025-12-17 | — | — | EP | claimed |
| EP-4537829-A2 | THERAPEUTIC COMPOSITIONS FOR DIABETIC SYMMETRICAL POLYNEUROPATHY | University Of Manitoba (CA) | 2025-04-16 | — | — | EP | claimed |
| US-20250090545-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES | UNIV MANITOBA (CA) | 2025-03-20 | — | — | US | claimed |
| WO-2025038382-A1 | PHARMACEUTICAL ADHESIVE COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2025-02-20 | — | — | WO | claimed |
| EP-3363439-B1 | THERAPEUTIC COMPOSITIONS FOR DIABETIC SYMMETRICAL POLYNEUROPATHY | UNIV MANITOBA (CA) | 2025-01-08 | — | — | EP | claimed |
| EP-3863708-B1 | MIXED IONIC CONDUCTORS AND CORRESPONDING DEVICES, SYSTEMS AND METHODS OF MAKING | BATTELLE MEMORIAL INSTITUTE (US) | 2024-09-11 | — | — | EP | claimed |
| US-20240180922-A1 | TREATMENTS FOR DIABETIC NEUROPATHY | UNIV MANITOBA (CA) | 2024-06-06 | — | — | US | claimed |
| US-11925649-B2 | Treatments for diabetic neuropathy | UNIVERSITY OF MANITOBA (CA) | 2024-03-12 | — | — | US | claimed |
| WO-2023225206-A1 | METHOD FOR ENHANCING REMYELINATION VIA CO-ADMINISTRATION OF MUSCARINIC RECEPTOR ANTAGONISTS AND VITAMIN D ANALOGUES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2023-11-23 | — | — | WO | claimed |
| US-20230190714-A1 | PRIMARY METHODS AND PROCESSES FOR LIFE EXTENSION IN MODERN-DAY HUMANS | POSTREL RICHARD (US) | 2023-06-22 | — | — | US | claimed |
| US-5356892-A | Administering anticholinergic muscarinic antagonist to control abnormal postnatal growth of eye of animal | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1994-10-18 | — | — | US | claimed |
| WO-1993018772-A1 | METHOD FOR REDUCING INTRAOCULAR PRESSURE IN THE MAMMALIAN EYE BY ADMINISTRATION OF MUSCARINIC ANTAGONISTS | ALLERGAN, INC. (US) | 1993-09-30 | — | — | WO | claimed |
| US-5140025-A | Telenzepine, ie, 4,9-dihydro-3-methyl-4-((4-methyl-1-piperazinyl)-acetyl)-1OH-thieno(3,4 -b)(1,5)-benzodiazepine | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1992-08-18 | — | — | US | claimed |
| EP-0478694-A4 | TREATMENT AND CONTROL OF OCULAR DEVELOPMENT | UNIV PENNSYLVANIA (US) | 1992-07-29 | — | — | EP | claimed |
| EP-0478694-A1 | TREATMENT AND CONTROL OF OCULAR DEVELOPMENT. | UNIV PENNSYLVANIA (US) | 1992-04-08 | — | — | EP | claimed |
| WO-1990015604-A1 | TREATMENT AND CONTROL OF OCULAR DEVELOPMENT | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1990-12-27 | — | — | WO | claimed |
| EP-0386145-A1 | THIENOTRICYCLENE FOR THE TREATMENT OF BRONCHIAL DISEASES | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1990-09-12 | — | — | EP | claimed |
| EP-0330756-A2 | Thienotricyclics for the treatment of bronchial diseases | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1989-09-06 | — | — | EP | claimed |
| WO-1989005644-A2 | THIENOTRICYCLENE FOR THE TREATMENT OF BRONCHIAL DISEASES | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1989-06-29 | — | — | WO | claimed |
| US-4381301-A | Substituted tricyclic thieno compounds, their synthesis, their use, their compositions and their medicaments | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1983-04-26 | — | — | US | claimed |